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Abstract  
Background:  Pharmaceutical  drug  promotion  is  a  means  of  informing  health  professionals  about  new  drugs.  The  approach  is  often  times 
unethical  and  inappropriate  and  may  promote  irrational  prescribing.  Dearth  of  information  on  impact  of  pharmaceutical  drug  promotion  on 
prescribing behaviour of doctors in developing African countries has necessitated this study. We therefore aimed to determine the sources of drug 
information  for  doctors  working  in  a  teaching  hospital  in  Nigeria  and  to  assess  the  self-reported  impact  of  the  sources  on  their  prescribing 
behaviour.  Methods:  A  total  of  163  doctors  working  at  the  University  College  Hospital  (UCH),  Ibadan  in  Nigeria  were  evaluated  with  a 
questionnaire for their demographics and sources of drug information. For doctors who relied on drug promotion, they were asked to self-report 
and self-rate their opinion on  extent of  interactions with pharmaceutical companies as well as how such interactions had impacted on their 
prescribing behaviour. Apart from the demographics, each question was evaluated with a typical five-level Likert item. Data analyses were with 
simple descriptive statistics. Results: Of the 400 doctors working at UCH, only 40.8% participated in the study. Drug information was sourced 
from colleagues (161, 98.8%), reference books (158, 96.9%), pharmaceutical sales representatives-PSRs (152, 93.2%), promotion materials (151, 
92.6%), scientific papers/journals/internet (149, 91.4%), and drug promotion forum/product launches (144, 88.3%). Each source was highly 
utilized but there was no wide variation in their pattern of use. According to the self-report of over a half of the respondents, PSRs was an accurate 
and reliable drug information resource; PSRs increased their awareness of the promoted drugs; and their prescribing behaviours were influenced 
by information from PSRs. Conclusion: Respondents tend to rely on a broad range of drug information resources which include potentially 
inappropriate resources such as PSRs. Since this study was based on self-report, the influence of drug information resources reported by the 
respondents on their prescribing behaviour may have been underestimated. Measures should be taken to minimize interactions between PSRs and 
the respondents.  
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Background 
 
Irrational prescription is a public health problem with the potential to harm both the individual and society. It is, possibly a contributory factor to 
the increasing pharmaceutical expenditure world-wide. Drug expenditure is a major concern for policy makers in Europe and has prompted them to 
suggest healthcare reforms [1].  
  
Several factors have been identified to influence doctors’ prescribing decisions and practice [2-4]. Some factors such as the physicians’ age and 
gender, their training, the socio-economic characteristics of the practicing environment, and the healthcare demand are fixed and may not offer 
much opportunity for modification and improvements in prescribing behaviour [5,6]. However, other factors including physicians’ level of education 
and experience, frequency of visits by pharmaceutical sales representatives (PSRs), number of patients examined per day, and various social 
factors are amenable to change and can be modified to improve physicians’ prescribing behaviour [7,8].  
  
Disease mongering is a potential means of creating an enormous market for drugs [9] but its influence on the prescribing behaviour of physicians 
has not been explored. Many normal life processes like birth, ageing, sexuality, unhappiness and death have been medicalised and are promoted 
as illnesses by the pharmaceutical industry [10]. Opinion leaders from the medical profession are used by the pharmaceutical industry to lure 
doctors to prescribe medicines for normal life processes when infact none is required [11].  
  
Drugs play an important role in the treatment of ill patients. In Nigeria, drugs are prescribed to more than 60 percent of the patients that consult 
with doctors [12,13]. PSRs are frequently the only source of information about medicines in developing countries where there may be as many as 
one representative for every five doctors [14].  
  
The  World  Health  Organization  (WHO)  defines  pharmaceutical  promotion  as  “all  information  and  persuasive  activities  by  manufacturers  and 
distributors, the effect of which is to induce the prescription, supply, purchase and/ or use of medicinal drugs” [15]. The WHO and some NGOs are 
bothered about the unethical and inappropriate approach to the promotion of pharmaceutical products. At the 1997 roundtable on WHO’s Ethical 
Criteria for Medicinal Drug Promotion there was firm agreement that inappropriate promotion of medicinal drugs remains a problem both in 
developing and developed countries [16]. Alongside the concern for unethical and inappropriate drug promotion, there is also increasing concern 
over irrational, inappropriate, or sometimes even harmful prescribing [17,18].  
  
Given the above problems and knowing that pharmaceutical companies play active roles in marketing their products, it is important to investigate 
how much influence these companies have on the prescribing behaviours of healthcare practitioners in developing African countries. Unfortunately, 
there is limited information on research in this area in Nigeria. This study is therefore aimed at determining the sources of drug information for 
doctors working in a teaching hospital in Nigeria and to assess the self-reported impact of the sources on their prescribing behaviour.  
  
  
Methods 
 
Study population  
  
This was a prospective study involving doctors working at the University College Hospital (UCH), Ibadan, Oyo State in Nigeria. UCH is a premier 
teaching hospital in South-western Nigeria. Approximately four hundred doctors are in the employment of this hospital. They are distributed into 
thirteen  departments  namely:  internal  medicine,  surgery,  paediatrics,  family  medicine,  obstetrics  and  gynaecology,  ophthalmology, 
otorhinolaryngology, radiology, radiotherapy, dentistry, community health, accident and emergency, orthopedics and trauma. Due to the small 
number of doctors in some departments and for the convenience of sample analysis, internal medicine and accident and emergency departments 
were grouped together as general medicine. Similarly, surgery, ortorhinolaryngology, and orthopedics and trauma departments were grouped 
together as surgery specialties. Only seven of these departments (general medicine, surgery specialties, paediatrics, family medicine, obstetrics 
and gynaecology, ophthalmology, and radiotherapy) were selected for this study. Other departments were excluded either because drugs were not 
routinely prescribed or because only a few varieties of drugs were routinely prescribed. Thus, the PSRs are likely to interact less with doctors from 
the excluded departments.  
  
Data collection  
  
A questionnaire was developed by the authors from previous studies that evaluated the influence of drug promotion on prescribing practices of 
doctors in developed [19,20] and developing countries [21,22], specifically for the purposes of this study.  
  
The questionnaire was in three sections. The first section focused on the demographics of the doctors; the second section asked doctors to 
indicate their response to a series of statements about their sources of information for prescribing and extent of their interactions with PSRs, in 
each  case  a  typical  five-level  Likert  item  was  used.  The  third  section  focused  on  the  perception  of  doctors  on  the  reliability  of  PSRs  and 
pharmaceutical materials as a source of prescribing information and how these factors would influence their prescribing behaviour. This last section 
also contains series of statements requiring responses using the five-level Likert item as it applied to the second section.  
  
The questionnaire was piloted among 10 doctors at the Lagos University Teaching Hospital (LUTH), Lagos, Nigeria and, after minor modifications; 
it was administered to the study population at UCH. Only the doctors who were willing to voluntarily participate were recruited for the study. The 
questionnaire was allowed a maximum of one week with each participant so as to allow enough time for the filling. In order to increase the 
response rates, the participants who were unable to produce the previous copy of the questionnaire were given a new one to be filled-in and 
returned  on  the  spot.  All  the  questionnaires  were  completed  anonymously.  Confidentiality  of  the  information  tendered  was  assured  to  the 
participants.  Page number not for citation purposes  3 
  
The ethics committee of UCH Ibadan approved the study.  
  
Data analysis  
  
The  data  obtained  were  analysed  with  SPSS  version  15. Results  were  presented  as  median  with  inter-quartile  range  (IQR)  for  time  related 
variables and as frequencies, percentages, and pictorial diagrams for responses to the questions in Likert-items.  
  
  
Results 
 
One hundred and sixty three (40.8%) of the 400 doctors working at the UCH Ibadan participated in the study. The characteristic features of the 
respondents are shown in Table 1. Responses to the second part of the questionnaire showed that all the doctors obtained drug information from 
more than one source which may explain the multiple responses to each of the questions. Of the 163 respondents, drug information was sourced 
from colleagues (161, 98.8%), drug reference books (158, 96.9%), PSRs (152, 93.2%), materials from drug companies (151, 92.6%), scientific 
papers/journals/internet (149, 91.4%), and drug promotion forum/product launches (144, 88.3%). The pattern of use of the drug information 
sources is presented in Figure 1. Although all the sources were highly utilized, there was no wide variation in their pattern of use. Seeking drug 
advice from colleagues was the most highly utilized source.  
  
Amongst the respondents who utilized each of the drug information sources, their frequency of use is as indicated in Figure 2. A few respondents 
always  rely  on  drug  information  from  colleagues,  materials  from  drug  companies,  or  drug  promotion/product  launches.  Over  a  half  of  the 
respondents regularly rely on their colleagues. Approximately 40% of the respondents occasionally rely on drug reference books, materials from 
dug companies, or drug promotion/product launches for prescribing information. Less than 10% of the respondents rarely consult their colleagues 
for prescribing information. There appears to be a wide variation in the frequency of use of the information sources.  
  
Multiple responses to the statements in the third section of the questionnaire were also observed in this study. This section assessed the impact of 
drug promotion by PSRs on the prescribing behaviours of the respondents. Their responses are as indicated in Table 2. Over a half of the 
respondents agreed that PSRs are efficient sources of drug information; accurate and reliable drug information can be sourced from PSRs; drug 
promotion  by  PSRs,  during  their  detailing,  do  increase  respondents’  awareness  of  the  promoted  drugs;  their  prescribing  behaviours  were 
influenced by drug information obtained from PSRs, this information was considered very useful and were readily used when prescribing. This 
group of respondents also agreed to prescribing promoted drugs if convinced of the information provided by the PSRs on the drug benefits. 
Approximately  one  tenth  of  the  respondents  strongly  agreed  to  most  of  the  statements  on  impact  of  drug  promotion  on  their  prescribing 
behaviours.  
  
  
Discussion 
 
Less than half of the doctors working at UCH participated in the study. This was probably due to pressure of work on the doctors which did not 
allow them the time to attend to the questionnaire. However, the relatively small population size (163) of the doctors who participated in this study 
is similar to the population (137 and 185 doctors) surveyed in other studies from North central and South-eastern Nigeria, respectively [21,23].  
  
The doctors relied on multiple sources of drug information as indicated by their high responses to each of the questions (Figure 1). Similar pattern 
of use of drug information resources has been reported among physicians in Greece and Cyprus [19], Australia [24], Ireland [25], Turkey [8], 
Nigeria [21], and Pakistan [26]. PSRs and promotional materials, as a source of drug information, may give new information about drugs; the 
benefits, efficacy and safety of such drugs may be exaggerated while their adverse effects downplayed [20,27]. The information contained in 
promotional materials and from the PSRs may or may not be as accurate as it appears [28]. Reliance on pharmaceutical promotions may therefore 
promote improper, inappropriate and undesirable prescribing practices [29,30].  
  
Over half of the doctors would regularly seek drug information from their colleagues compared to less than a half that would occasionally consult 
reference books. Previous studies have shown that reliance on colleagues was the most highly ranked information source preference by rural and 
urban primary care doctors in the United States of America [31,32] and the General Practitioners in Ireland [25].This practice was referred to by 
Williamson as a preference for human sources rather than paper sources [33].The costs associated with acquiring information from reference 
books, internet and journals are likely to be bore by individual doctors in resource poor countries like Nigeria and may be more of a burden to the 
doctors. This may explain why the respondents rely more on human drug information source which attracts no cost. It should be recognised that in 
a self-report study like this, the respondents are likely to rate their colleagues highly as a source of drug information but in practice, other 
information sources may be highly utilised. This is however a limitation of self-report studies [25].  
  
Over  40%  of  the  respondents  occasionally  rely  on  information  from  pharmaceutical  companies  or  drug  promotion  forum/product  launches. 
Reliance majorly on these sources for drug information is very rampant in many developing [21,23,26] and some developed countries [24,34]. 
These materials can be highly informative as long as they are critically appraised [35]. Their use without appropriate appraisal may promote 
irrational prescribing. In Nigeria, doctors may find it difficult to discuss the validity of drug information in promotional materials because critical 
appraisal of such information is not taught in medical schools. Thus, integrating teaching of ethical issues surrounding drug promotion and critical 
appraisal of promotion materials into medical curriculum, and proper assessment of students; both theoretically and practically, may reduce the 
extent of doctors’ reliance on promotional materials and PSRs for accurate drug information.  
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Another limitation of a self-report study is underestimation of the effect of pharmaceutical promotion on the prescribing behaviour of doctors which 
are recognised limitations of the previous studies [8,17]. In our study, over 50% of the respondents self-reported that PSRs was a good, accurate 
and reliable drug information source. This finding may however differ in practice. It may however explain why many of the respondents found 
information  from  PSRs  very  useful  and  ready  to  use  when  prescribing.  This  further  emphasizes  the  need  to  teach  critical  appraisal  of  drug 
information from pharmaceutical industry as a potentially useful information resource. Educational intervention programmes on rational drug use 
may therefore be necessary to provide a framework for prescribers to objectively assess information provided by PSRs before deciding to prescribe 
their products. Teaching medical students how to appropriately interact with PSRs has been reported to impact positively on their prescribing 
attitudes [36].  
  
Doctors may not be aware of how much they are exposed to drug promotion, thus a self-report study like this may not have appropriately 
assessed the impact of drug promotion on prescribing behaviour of the doctors. Further studies that would establish causal relationships between 
exposure to drug promotion and the prescribing habits of the doctors are therefore suggested. The small study population and focusing on only 
one institution in Nigeria may limit the generalizability of our results. It is to be hoped that a national survey that will involve doctors from many 
hospitals in Nigeria would address these problems in the future.  
  
  
Conclusion 
 
Reliance on a wide range drug information resource is commonly practiced by the respondents. The use of potentially inappropriate information 
resources remains a major challenge facing the respondents and of concern for rational prescribing. Interventions in the form of continuous 
medical education may be required to improve their information-seeking behaviours. It is self-reported by the respondents that pharmaceutical 
companies influenced their prescribing behaviour. Measures may be necessary to minimize interactions between PSRs and the respondents.  
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Table 1: The demographics and characteristic features of the respondents 
Characteristics  Values 
Median age (years)  36 (IQR 32–48) 
Median year of practice in a teaching hospital (years)  6.9 (IQR 1.6- 16.5) 
Male: female ratio  1.6: 1 
Cadre   
House officers  24 (14.7%) 
Medical officers  22 (13.5%) 
Junior residents  45 (27.6%) 
Senior residents  48 (29.4%) 
Consultants  24 (14.7%) 
Area of specialization   
General medicine  38 (23.4%) 
Obstetrics and gynaecology  31 (19.0%) 
Family medicine  29 (17.8%) 
Surgery specialties  24 (18.4%) 
Paediatrics  17 (10.4%) 
Ophthalmology  11 (6.7%) 
Radiotherapy  7 (4.3%) 
IQR: inter Quartile range    
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Table 2: Impact of drug promotion on the prescribing behaviours of a group doctors in a teaching hospital in Ibadan, Nigeria 
   Responses (n=163) 
Statements  Strongly agree 
(%) 
Agree 
(%) 
Undecided 
(%) 
Strongly 
disagree (%) 
Disagree 
(%) 
PSRs is an efficient source of drug information  17.2  52.8  18.4  9.8  1.8 
Drug information from PSRs is accurate and reliable  12.3  53.4  23.3  9.2  1.8 
Detailing of a PSR increases my awareness of promoted drug  16.6  65.6  12.9  3.7  1.2 
Detailing of a PSR increases my preference for prescribing the promoted drug  13.5  46.0  29.4  9.2  1.8 
Drug information from PSRs influenced my informed decision to prescribe  13.5  58.9  20.9  4.3  2.5 
If convinced of a drug benefits by PSRs, I will prescribe to patients  22.1  60.7  9.2  6.1  1.8 
Drug information from PSRs is often irrelevant  1.8  10.4  22.1  50.3  15.3 
PSRs are good sources of drug information but rely less on them when prescribing  8.6  33.7  25.2  5.2  7.4 
PSRs induce me to prescribe branded drugs even when generics are available  15.3  21.5  20.2  27.6  15.3 
Drug information from other sources more important and reliable than from PSRs  11.7  33.1  22.7  27.0  5.5 
Drug information from PSRs is usually useful and readily used when prescribing  16.6  52.8  21.5  6.7  2.5 
PSR: pharmaceutical sales representatives Page number not for citation purposes  9 
 
 
 
 
 
 
 
 
 
 